THROSBY, Mark,GEUIJEN, Cecilia Anna Wilhelmina,MAUSSANG-DETAILLE, David Andre Baptiste,LOGTENBERG, Ton
申请号：
PH12019550202
公开号：
PH12019550202A1
申请日:
2019.09.27
申请国别(地区):
PH
年份:
2020
代理人:
摘要：
The invention relates to the field of antibodies. In particular it relates to the field of therapeutic (human) antibodies for the treatment of ErbB-2/ErbB-3 positive cells. More in particular it relates to treating of cells comprising an NRG1 fusion gene comprising at least a portion of the NRG1-gene fused to a sequence from a different chromosomal location.
